VCYTVeracyte, Inc.
What is the market doing?
No clear lean: in an uptrend, but heavily shorted (+13% of shares).
In an uptrend, above its rising 50- and 200-day averages. Price is +8% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 9, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 21% since the previous count, up from 8.3% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How VCYT is trading
Veracyte, Inc. is +33% over the past year while the S&P 500 is +18%: 14 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +8.4%
vs 200-day average · close to trend
- RSI (14)
- 58
RSI (14) · neutral
- Below its 52-week high
- 24%
Below its 52-week high
Details›
- Last close2026-10-09
- $45.23
- 1 monthS&P 500 +2.7%
- +7.7%
- 1 yearS&P 500 +18%
- +33%
- 5 yearsS&P 500 +88%
- −3.6%
- vs 50-day average$44.15
- +2.4%
- 52-week high
- $59.55
- 52-week low
- $30.01
- Annualised volatility
- 57%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-09
- −$1.1M
| Year | Return |
|---|---|
| 2026 (year to date) | +7.4% |
| 2025 | +6.3% |
| 2024 | +44% |
| 2023 | +16% |
| 2022 | −42% |
| 2021 | −16% |
| 2020 | +75% |
| 2019 | +122% |
| 2018 | +93% |
| 2017 | −16% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +2.4% |
| Feb | 10 | 3 of 10 | −3.7% |
| Mar | 10 | 2 of 10 | −1.7% |
| Apr | 10 | 5 of 10 | −3.5% |
| May | 10 | 4 of 10 | +2.7% |
| Jun | 10 | 9 of 10 | +10% |
| Jul | 11 | 6 of 11 | +8.4% |
| Aug | 11 | 6 of 11 | +3.6% |
| Sep | 11 | 5 of 11 | −0.36% |
| Oct | 11 | 5 of 11 | +6.4% |
| Nov | 10 | 7 of 10 | +16% |
| Dec | 10 | 3 of 10 | −3.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Diagnostics & Research
Ranks #8 of 21 by RyuScore